Comparison of P2Y<sub>12</sub> inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis.

Arch Med Sci Atheroscler Dis · 2026 · PMC13248930 · PMID 42273658

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The trend toward fewer MIs on P2Y 12 therapy, seen in RCTs, did not reach statistical significance overall; larger trials or individual-patient data meta-analyses may be needed to clarify this.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparison of P2Y&lt;sub&gt;12&lt;/sub&gt; inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis.

The sentences

Comparison of P2Y<sub>12</sub> inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis.